← back to search

Milena Di Leo

AOL (United States) · US
Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Esophageal and GI Pathology, and Gallbladder and Bile Duct Disorders.
h-index
31
citations
3,537
works
162
NIH funding
primary concept
Medicine
email

Recent publications

Establishing the optimal number of passes during EUS-FNB for diagnosis of pancreatic solid lesions: Prospective multicenter study
Endoscopy International Open 2024cited by 10position: middledoi
IS ONE PASS ENOUGH FOR THE DIAGNOSIS OF THE PANCREATlC MASSES DURING EUS-FNB? A PROSPECTIVE STUD
Endoscopy 2023cited by 0position: middledoi
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma
Carcinogenesis 2021cited by 31position: middledoi
Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial
Gastroenterology 2020cited by 593position: middledoi
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey
Digestive and Liver Disease 2020cited by 38position: middledoi
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk.
Pancreatology 2020cited by 1position: middledoi
Germline <i>BRCA2</i> K3326X and <i>CHEK2</i> I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
International Journal of Cancer 2019cited by 31position: middledoi
Genome-wide association study identifies inversion in the <i>CTRB1-CTRB2</i> locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis
Gut 2017cited by 133position: middledoi
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation
International Journal of Cancer 2017cited by 17position: middledoi
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk
Oncotarget 2016cited by 56position: middledoi
A single-centre prospective, cohort study of the natural history of acute pancreatitis
Digestive and Liver Disease 2014cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alessandro Repici · Sapienza University of Rome3 papers (2020–2024)Silvia Carrara · Humanitas University3 papers (2020–2024) · 2 papers (2023–2024)Francesco Maria Di Matteo · Università Campus Bio-Medico2 papers (2023–2024)Stefano Francesco Crinò · University of Verona2 papers (2023–2024)Serena Stigliano · Università Campus Bio-Medico2 papers (2023–2024)Antonio Facciorusso · Collaborative Group (United States)2 papers (2023–2024)Cesare Hassan · William S. Middleton Memorial Veterans Hospital2 papers (2020–2024) · 2 papers (2023–2024)Pietro Fusaroli · McGill University2 papers (2023–2024)Emanuele Dabizzi · Second Military Medical University2 papers (2023–2024)Benedetto Mangiavillano · Humanitas University2 papers (2023–2024)Marco Spadaccini · Humanitas University2 papers (2020–2023)Paolo Giorgio Arcidiacono · Vita-Salute San Raffaele University1 papers (2014–2014) · 1 papers (2024–2024)Vincenzo Craviotto · IRCCS Humanitas Research Hospital1 papers (2020–2020)Roberta Maselli · Humanitas University1 papers (2020–2020)Gianenrico Rizzatti · University of the Sacred Heart1 papers (2024–2024)Prateek Sharma · Harm Reduction Services1 papers (2020–2020)Matteo Badalamenti · IRCCS Humanitas Research Hospital1 papers (2020–2020)